LifeMD, Inc.
LFMD
$3.90
-$0.19-4.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -22.11% | -1.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -22.11% | -1.53% | |||
| Cost of Revenue | -18.66% | -0.31% | |||
| Gross Profit | -22.59% | -1.69% | |||
| SG&A Expenses | -24.65% | -2.05% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 14.35% | -1.16% | |||
| Total Operating Expenses | -22.81% | -1.56% | |||
| Operating Income | 44.26% | 2.52% | |||
| Income Before Tax | 68.31% | -26.25% | |||
| Income Tax Expenses | -91.78% | -- | |||
| Earnings from Continuing Operations | 69.42% | -32.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 108.30% | 50.60% | |||
| Net Income | 624.52% | -19.38% | |||
| EBIT | 44.26% | 2.52% | |||
| EBITDA | 45.43% | 8.73% | |||
| EPS Basic | 513.09% | -11.32% | |||
| Normalized Basic EPS | 60.96% | 27.49% | |||
| EPS Diluted | 509.60% | -12.11% | |||
| Normalized Diluted EPS | 60.96% | 27.49% | |||
| Average Basic Shares Outstanding | 1.32% | 3.90% | |||
| Average Diluted Shares Outstanding | 1.32% | 3.90% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 1.19% | 0.16% | |||